A new oral weight-loss drug from Pfizer could be more effective than the popular Ozempic injection, based on clinical trial results.
Share:
More In Business
Texas Supreme Court Rejects Challenge to State’s Abortion Law
Friday's ruling from the court is the latest decision to uphold Texas’ abortion ban, which critics say does not offer enough clarity over exceptions.
Would You Trust A.I. to Manage Your Money?
Northwestern Mutual’s A.I. and money report shows that consumers want their adviser to take advantage of ‘superpowers’ granted by artificial intelligence tools.
CEOs Got Hefty Pay Raises in 2023, Widening The Gap with Workers
The typical compensation package for chief executives who run companies in the S&P 500 jumped nearly 13 percent last year.
Meme Stocks Are Roaring Again. Yes, Again.
GameStop and other meme stocks are roaring once again, surging to dizzying heights suddenly and sharply.
Don’t Get Played by the GameStop Rally, This Analyst Says
While 'meme stocks' like GameStop, AMC, and even Reddit are popping, one expert says he's advising clients to steer clear.
FDRA CEO Talks Inflation, Tariffs On Footwear
The FDRA is a trade association that supports nearly 500 brands worldwide including Nike, Adidas, Walmart, and Target and represents over 90% of US shoe sales.
Traveling Paws-itively: BARK Air Offers Flights for Furry Friends
BARK Air offers a luxurious travel experience for dogs and their owners, setting a new standard for pet-friendly travel.
Will Business At The Box Office Rebound After Memorial Day Weekend?
Lead Analyst at TVREV, Alan Wolk, joins Cheddar to discuss the latest in media and business news, including why business at the box office may be slowing down.
Be Prepared for No Rate Cuts in 2024
With stubborn inflation sticking at about 2.8%, there’s a chance that the Fed won’t cut rates this year. That might be the smarter choice in the long run.
